Literature DB >> 2873141

IMP dehydrogenase from the intracellular parasitic protozoan Eimeria tenella and its inhibition by mycophenolic acid.

D J Hupe, B A Azzolina, N D Behrens.   

Abstract

Mycophenolic acid (MA) was demonstrated to be an effective inhibitor of the growth of the intracellular parasitic protozoan Eimeria tenella in tissue culture and guanine was shown to reverse this inhibition as expected for an inhibitor of IMP dehydrogenase (IMP:NAD+ oxidoreductase, EC 1.1.1.205). A high performance liquid chromatography study of the intracellular nucleotide pools labeled with [3H]hypoxanthine was carried out in host cells lacking hypoxanthine-guanine phosphoribosyltransferase, and the depletion of guanine nucleotides demonstrated that the intracellular parasite enzyme was being inhibited by the drug. Kinetic studies carried out on the enzyme derived from E. tenella oocysts demonstrated substrate inhibition by NAD and mycophenolic acid inhibition similar to that found for mammalian enzymes, but different from that for bacterial enzymes. The inhibition by mycophenolic acid was not time-dependent and was immediately reversed upon dilution. As found previously for other IMP dehydrogenases, an Ordered Bi-Bi mechanism prevails with IMP on first followed by NAD, NADH off first, and then XMP. The kinetic patterns are consistent with substrate inhibition at high concentrations of NAD due to the formation of an E X XMP X NAD complex. Uncompetitive inhibition by MA versus IMP, NAD, and K+ was found and this was interpreted as evidence for the formation of an E X XMP X MA complex. A speculative mechanism for the inhibition of the enzyme is offered which is consistent with the fact that E X XMP X MA readily forms, whereas E X IMP X MA does not.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873141

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Three enzymes newly identified from the genus Eimeria and two more newly identified from E. maxima, leading to the discovery of some aliphatic acids with activity against coccidia of the domesticated fowl.

Authors:  R B Williams
Journal:  Vet Res Commun       Date:  1999-05       Impact factor: 2.459

Review 2.  The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors.

Authors:  L Hedstrom; G Liechti; J B Goldberg; D R Gollapalli
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  In vivo expression of in vitro anticoccidial activity.

Authors:  A P Ricketts; J A Olson; J R Rice
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

Review 4.  IMP dehydrogenase: structure, mechanism, and inhibition.

Authors:  Lizbeth Hedstrom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

5.  6-Azauracil inhibition of GTP biosynthesis in Saccharomyces cerevisiae.

Authors:  F Exinger; F Lacroute
Journal:  Curr Genet       Date:  1992-07       Impact factor: 3.886

6.  IMP dehydrogenase from Pneumocystis carinii as a potential drug target.

Authors:  M J O'Gara; C H Lee; G A Weinberg; J M Nott; S F Queener
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

7.  IMP dehydrogenase from the protozoan parasite Toxoplasma gondii.

Authors:  William J Sullivan; Stacy E Dixon; Catherine Li; Boris Striepen; Sherry F Queener
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

8.  The raspberry locus encodes Drosophila inosine monophosphate dehydrogenase.

Authors:  R Slee; M Bownes
Journal:  Mol Gen Genet       Date:  1995-10-25

9.  Bioavailability improvement of mycophenolic acid through amino ester derivatization.

Authors:  W A Lee; L Gu; A R Miksztal; N Chu; K Leung; P H Nelson
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

10.  Inhibition of reovirus by mycophenolic acid is associated with the M1 genome segment.

Authors:  Laura L Hermann; Kevin M Coombs
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.